Assessment of relative quantitative effect of somatic point mutations at the individual tumor level for prioritization
Computational model to assess the relative strength of every point mutation is 535 (now expanded to >700) cancer genes.
- This is a continuous quantitative model
- This model is available for 535 cancer genes but only for variants that occurred
- Germline variants: genetic consultation for carrier of mutations. The model has potential to assess relative risk
- Somatic variants: Identification of mutations to target for precision medicine in cancer. The model can prioritize genetic profile of each tumor for drug targeting
Priority application filed